Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.

about

MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1

P2860

Q41547637-AB7C3BBF-08C4-4E9D-AC45-741650A4B2BA

P2860

Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.

Item

http://www.wikidata.org/entity/Q39350373

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Updates for the radiologist in ...... and metastatic bladder cancer.

@en

Updates for the radiologist in ...... and metastatic bladder cancer.

@nl

type

Item

label

Updates for the radiologist in ...... and metastatic bladder cancer.

@en

Updates for the radiologist in ...... and metastatic bladder cancer.

@nl

prefLabel

Updates for the radiologist in ...... and metastatic bladder cancer.

@en

Updates for the radiologist in ...... and metastatic bladder cancer.

@nl

P1476

Updates for the radiologist in ...... and metastatic bladder cancer

@en

P2093

Atul B Shinagare

http://www.w3.org/2001/XMLSchema#string

Katherine M Krajewski

http://www.w3.org/2001/XMLSchema#string

Kyung Won Kim

http://www.w3.org/2001/XMLSchema#string

Marta Braschi-Amirfarzan

http://www.w3.org/2001/XMLSchema#string

Nikhil H Ramaiya

http://www.w3.org/2001/XMLSchema#string

Sree Harsha Tirumani

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

Comprehensive molecular characterization of urothelial bladder carcinoma

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation.

Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.

Nodal staging.

Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology.

Cancer immunotherapy and immune-related response assessment: The role of radiologists in the new arena of cancer treatment.

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

MDCT urography of upper tract urothelial neoplasms.

P2888

s00261-017-1195-3

P304

2710-2724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00261-017-1195-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jooae Choe

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28580540

http://www.w3.org/2001/XMLSchema#string

Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.

about

P2860

P2860

Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698